nodes	percent_of_prediction	percent_of_DWPC	metapath
Cysteamine—SST—cranial nerve—head and neck cancer	0.113	0.264	CbGeAlD
Cysteamine—SST—exocrine gland—head and neck cancer	0.0509	0.119	CbGeAlD
Cysteamine—Gastrointestinal ulcer—Hydroxyurea—head and neck cancer	0.0464	0.149	CcSEcCtD
Cysteamine—MPO—saliva—head and neck cancer	0.0406	0.0948	CbGeAlD
Cysteamine—NPY2R—head—head and neck cancer	0.0352	0.0823	CbGeAlD
Cysteamine—SST—neck—head and neck cancer	0.0326	0.0761	CbGeAlD
Cysteamine—Gastrointestinal ulcer haemorrhage—Fluorouracil—head and neck cancer	0.0269	0.0866	CcSEcCtD
Cysteamine—SST—connective tissue—head and neck cancer	0.0233	0.0545	CbGeAlD
Cysteamine—SST—epithelium—head and neck cancer	0.0222	0.0518	CbGeAlD
Cysteamine—SST—trachea—head and neck cancer	0.0196	0.0458	CbGeAlD
Cysteamine—SST—lymphoid tissue—head and neck cancer	0.0171	0.0399	CbGeAlD
Cysteamine—SST—thyroid gland—head and neck cancer	0.0155	0.0362	CbGeAlD
Cysteamine—SST—Peptide ligand-binding receptors—KISS1—head and neck cancer	0.0139	0.0531	CbGpPWpGaD
Cysteamine—SST—head—head and neck cancer	0.0137	0.0321	CbGeAlD
Cysteamine—NPY2R—Peptide ligand-binding receptors—KISS1—head and neck cancer	0.0133	0.0509	CbGpPWpGaD
Cysteamine—SST—Peptide ligand-binding receptors—GRP—head and neck cancer	0.0114	0.0437	CbGpPWpGaD
Cysteamine—NPY2R—Peptide ligand-binding receptors—GRP—head and neck cancer	0.0109	0.0419	CbGpPWpGaD
Cysteamine—MPO—C-MYB transcription factor network—CEBPA—head and neck cancer	0.0106	0.0406	CbGpPWpGaD
Cysteamine—SST—lymph node—head and neck cancer	0.00963	0.0225	CbGeAlD
Cysteamine—MPO—connective tissue—head and neck cancer	0.0094	0.022	CbGeAlD
Cysteamine—MPO—C-MYB transcription factor network—CCNA1—head and neck cancer	0.00933	0.0357	CbGpPWpGaD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—KISS1—head and neck cancer	0.0093	0.0356	CbGpPWpGaD
Cysteamine—MPO—epithelium—head and neck cancer	0.00892	0.0209	CbGeAlD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—KISS1—head and neck cancer	0.00891	0.0341	CbGpPWpGaD
Cysteamine—Encephalopathy—Fluorouracil—head and neck cancer	0.00804	0.0259	CcSEcCtD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—GRP—head and neck cancer	0.00766	0.0293	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—GRP—head and neck cancer	0.00734	0.0281	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—KISS1—head and neck cancer	0.00708	0.0271	CbGpPWpGaD
Cysteamine—MPO—lymphoid tissue—head and neck cancer	0.00687	0.0161	CbGeAlD
Cysteamine—NPY2R—GPCR ligand binding—KISS1—head and neck cancer	0.00679	0.026	CbGpPWpGaD
Cysteamine—MPO—Vitamin B12 Metabolism—SOD2—head and neck cancer	0.00666	0.0255	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—GRP—head and neck cancer	0.00583	0.0223	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—GRP—head and neck cancer	0.00559	0.0214	CbGpPWpGaD
Cysteamine—MPO—head—head and neck cancer	0.00554	0.0129	CbGeAlD
Cysteamine—Redness—Docetaxel—head and neck cancer	0.00552	0.0178	CcSEcCtD
Cysteamine—MPO—Folate Metabolism—SOD2—head and neck cancer	0.00542	0.0208	CbGpPWpGaD
Cysteamine—NPY2R—Circadian rythm related genes—TYMS—head and neck cancer	0.0054	0.0207	CbGpPWpGaD
Cysteamine—MPO—Folate Metabolism—GPX1—head and neck cancer	0.00517	0.0198	CbGpPWpGaD
Cysteamine—Scotoma—Docetaxel—head and neck cancer	0.00491	0.0158	CcSEcCtD
Cysteamine—MPO—IL23-mediated signaling events—IL2—head and neck cancer	0.00448	0.0172	CbGpPWpGaD
Cysteamine—MPO—C-MYB transcription factor network—GSTM1—head and neck cancer	0.00445	0.017	CbGpPWpGaD
Cysteamine—MPO—Selenium Micronutrient Network—SOD2—head and neck cancer	0.00431	0.0165	CbGpPWpGaD
Cysteamine—Bone disorder—Docetaxel—head and neck cancer	0.00412	0.0133	CcSEcCtD
Cysteamine—MPO—Selenium Micronutrient Network—GPX1—head and neck cancer	0.00411	0.0157	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—KISS1—head and neck cancer	0.004	0.0153	CbGpPWpGaD
Cysteamine—MPO—lymph node—head and neck cancer	0.00388	0.00906	CbGeAlD
Cysteamine—NPY2R—GPCR downstream signaling—KISS1—head and neck cancer	0.00384	0.0147	CbGpPWpGaD
Cysteamine—Lethargy—Fluorouracil—head and neck cancer	0.00382	0.0123	CcSEcCtD
Cysteamine—MPO—IL23-mediated signaling events—STAT3—head and neck cancer	0.00377	0.0144	CbGpPWpGaD
Cysteamine—Phosphatase alkaline increased—Docetaxel—head and neck cancer	0.00373	0.012	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—KISS1—head and neck cancer	0.00363	0.0139	CbGpPWpGaD
Cysteamine—Hallucination—Hydroxyurea—head and neck cancer	0.00358	0.0115	CcSEcCtD
Cysteamine—Ataxia—Fluorouracil—head and neck cancer	0.00352	0.0113	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—KISS1—head and neck cancer	0.00348	0.0133	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—GRP—head and neck cancer	0.00329	0.0126	CbGpPWpGaD
Cysteamine—Anaemia—Vinblastine—head and neck cancer	0.00318	0.0102	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—GRP—head and neck cancer	0.00316	0.0121	CbGpPWpGaD
Cysteamine—Erythema—Hydroxyurea—head and neck cancer	0.00314	0.0101	CcSEcCtD
Cysteamine—Blood alkaline phosphatase increased—Docetaxel—head and neck cancer	0.00311	0.01	CcSEcCtD
Cysteamine—Leukopenia—Vinblastine—head and neck cancer	0.00308	0.0099	CcSEcCtD
Cysteamine—SST—SIDS Susceptibility Pathways—VEGFA—head and neck cancer	0.00303	0.0116	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—GRP—head and neck cancer	0.00299	0.0115	CbGpPWpGaD
Cysteamine—Convulsion—Vinblastine—head and neck cancer	0.00298	0.00958	CcSEcCtD
Cysteamine—MPO—IL23-mediated signaling events—PIK3CA—head and neck cancer	0.00298	0.0114	CbGpPWpGaD
Cysteamine—Hypertension—Vinblastine—head and neck cancer	0.00297	0.00955	CcSEcCtD
Cysteamine—Anaemia—Hydroxyurea—head and neck cancer	0.0029	0.00932	CcSEcCtD
Cysteamine—Discomfort—Vinblastine—head and neck cancer	0.00289	0.0093	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—GRP—head and neck cancer	0.00287	0.011	CbGpPWpGaD
Cysteamine—MPO—Folate Metabolism—IL2—head and neck cancer	0.00282	0.0108	CbGpPWpGaD
Cysteamine—Leukopenia—Hydroxyurea—head and neck cancer	0.00281	0.00903	CcSEcCtD
Cysteamine—Lethargy—Docetaxel—head and neck cancer	0.00276	0.00888	CcSEcCtD
Cysteamine—Convulsion—Hydroxyurea—head and neck cancer	0.00272	0.00874	CcSEcCtD
Cysteamine—Pain in extremity—Docetaxel—head and neck cancer	0.0027	0.0087	CcSEcCtD
Cysteamine—Anorexia—Vinblastine—head and neck cancer	0.00267	0.0086	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00265	0.00852	CcSEcCtD
Cysteamine—MPO—C-MYB transcription factor network—BCL2—head and neck cancer	0.00264	0.0101	CbGpPWpGaD
Cysteamine—Discomfort—Hydroxyurea—head and neck cancer	0.00264	0.00848	CcSEcCtD
Cysteamine—NPY2R—Circadian rythm related genes—PTEN—head and neck cancer	0.00262	0.01	CbGpPWpGaD
Cysteamine—Ataxia—Docetaxel—head and neck cancer	0.00254	0.00818	CcSEcCtD
Cysteamine—Dehydration—Docetaxel—head and neck cancer	0.00252	0.00809	CcSEcCtD
Cysteamine—MPO—C-MYB transcription factor network—PTGS2—head and neck cancer	0.00251	0.00961	CbGpPWpGaD
Cysteamine—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00251	0.00807	CcSEcCtD
Cysteamine—Liver function test abnormal—Docetaxel—head and neck cancer	0.0025	0.00803	CcSEcCtD
Cysteamine—Skin disorder—Hydroxyurea—head and neck cancer	0.00249	0.00799	CcSEcCtD
Cysteamine—Anorexia—Hydroxyurea—head and neck cancer	0.00244	0.00784	CcSEcCtD
Cysteamine—Decreased appetite—Vinblastine—head and neck cancer	0.00244	0.00784	CcSEcCtD
Cysteamine—MPO—Selenium Micronutrient Network—PTGS2—head and neck cancer	0.00242	0.00926	CbGpPWpGaD
Cysteamine—Constipation—Vinblastine—head and neck cancer	0.0024	0.00772	CcSEcCtD
Cysteamine—Feeling abnormal—Vinblastine—head and neck cancer	0.00231	0.00744	CcSEcCtD
Cysteamine—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00229	0.00738	CcSEcCtD
Cysteamine—Somnolence—Hydroxyurea—head and neck cancer	0.00227	0.00732	CcSEcCtD
Cysteamine—MPO—C-MYB transcription factor network—CCND1—head and neck cancer	0.00227	0.00868	CbGpPWpGaD
Cysteamine—Erythema—Fluorouracil—head and neck cancer	0.00226	0.00726	CcSEcCtD
Cysteamine—Dyspepsia—Hydroxyurea—head and neck cancer	0.00225	0.00724	CcSEcCtD
Cysteamine—Decreased appetite—Hydroxyurea—head and neck cancer	0.00222	0.00715	CcSEcCtD
Cysteamine—Abdominal pain—Vinblastine—head and neck cancer	0.00222	0.00713	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00221	0.0071	CcSEcCtD
Cysteamine—Fatigue—Hydroxyurea—head and neck cancer	0.00221	0.00709	CcSEcCtD
Cysteamine—Constipation—Hydroxyurea—head and neck cancer	0.00219	0.00704	CcSEcCtD
Cysteamine—SST—Signaling Pathways—KISS1—head and neck cancer	0.00215	0.00822	CbGpPWpGaD
Cysteamine—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00211	0.00678	CcSEcCtD
Cysteamine—Anaemia—Fluorouracil—head and neck cancer	0.00209	0.00671	CcSEcCtD
Cysteamine—Hypersensitivity—Vinblastine—head and neck cancer	0.00207	0.00665	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—KISS1—head and neck cancer	0.00206	0.00788	CbGpPWpGaD
Cysteamine—Renal failure—Docetaxel—head and neck cancer	0.00205	0.00659	CcSEcCtD
Cysteamine—Body temperature increased—Hydroxyurea—head and neck cancer	0.00202	0.00651	CcSEcCtD
Cysteamine—Leukopenia—Fluorouracil—head and neck cancer	0.00202	0.0065	CcSEcCtD
Cysteamine—Asthenia—Vinblastine—head and neck cancer	0.00201	0.00647	CcSEcCtD
Cysteamine—Convulsion—Fluorouracil—head and neck cancer	0.00196	0.00629	CcSEcCtD
Cysteamine—Diarrhoea—Vinblastine—head and neck cancer	0.00192	0.00617	CcSEcCtD
Cysteamine—Discomfort—Fluorouracil—head and neck cancer	0.0019	0.0061	CcSEcCtD
Cysteamine—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00189	0.00606	CcSEcCtD
Cysteamine—Confusional state—Fluorouracil—head and neck cancer	0.00186	0.00597	CcSEcCtD
Cysteamine—Dizziness—Vinblastine—head and neck cancer	0.00186	0.00597	CcSEcCtD
Cysteamine—Urinary tract disorder—Docetaxel—head and neck cancer	0.00185	0.00594	CcSEcCtD
Cysteamine—Anaphylactic shock—Fluorouracil—head and neck cancer	0.00184	0.00592	CcSEcCtD
Cysteamine—Connective tissue disorder—Docetaxel—head and neck cancer	0.00184	0.00591	CcSEcCtD
Cysteamine—Asthenia—Hydroxyurea—head and neck cancer	0.00184	0.0059	CcSEcCtD
Cysteamine—Urethral disorder—Docetaxel—head and neck cancer	0.00183	0.0059	CcSEcCtD
Cysteamine—MPO—Folate Metabolism—TP53—head and neck cancer	0.00181	0.00694	CbGpPWpGaD
Cysteamine—Nervous system disorder—Fluorouracil—head and neck cancer	0.00181	0.00581	CcSEcCtD
Cysteamine—NPY2R—Circadian rythm related genes—TP53—head and neck cancer	0.00179	0.00685	CbGpPWpGaD
Cysteamine—Vomiting—Vinblastine—head and neck cancer	0.00178	0.00574	CcSEcCtD
Cysteamine—SST—Signaling Pathways—GRP—head and neck cancer	0.00177	0.00677	CbGpPWpGaD
Cysteamine—Headache—Vinblastine—head and neck cancer	0.00176	0.00565	CcSEcCtD
Cysteamine—Anorexia—Fluorouracil—head and neck cancer	0.00176	0.00565	CcSEcCtD
Cysteamine—Diarrhoea—Hydroxyurea—head and neck cancer	0.00175	0.00563	CcSEcCtD
Cysteamine—SST—Signaling Pathways—STAT6—head and neck cancer	0.00172	0.00657	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—GRP—head and neck cancer	0.00169	0.00649	CbGpPWpGaD
Cysteamine—Dizziness—Hydroxyurea—head and neck cancer	0.00169	0.00544	CcSEcCtD
Cysteamine—Immune system disorder—Docetaxel—head and neck cancer	0.00169	0.00544	CcSEcCtD
Cysteamine—Nausea—Vinblastine—head and neck cancer	0.00167	0.00536	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—STAT6—head and neck cancer	0.00164	0.0063	CbGpPWpGaD
Cysteamine—Mental disorder—Docetaxel—head and neck cancer	0.00164	0.00527	CcSEcCtD
Cysteamine—Somnolence—Fluorouracil—head and neck cancer	0.00164	0.00527	CcSEcCtD
Cysteamine—Malnutrition—Docetaxel—head and neck cancer	0.00163	0.00524	CcSEcCtD
Cysteamine—Erythema—Docetaxel—head and neck cancer	0.00163	0.00524	CcSEcCtD
Cysteamine—Vomiting—Hydroxyurea—head and neck cancer	0.00163	0.00523	CcSEcCtD
Cysteamine—Dyspepsia—Fluorouracil—head and neck cancer	0.00162	0.00521	CcSEcCtD
Cysteamine—Rash—Hydroxyurea—head and neck cancer	0.00161	0.00519	CcSEcCtD
Cysteamine—Dermatitis—Hydroxyurea—head and neck cancer	0.00161	0.00518	CcSEcCtD
Cysteamine—Headache—Hydroxyurea—head and neck cancer	0.0016	0.00516	CcSEcCtD
Cysteamine—Decreased appetite—Fluorouracil—head and neck cancer	0.0016	0.00515	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00159	0.00511	CcSEcCtD
Cysteamine—Nausea—Hydroxyurea—head and neck cancer	0.00152	0.00489	CcSEcCtD
Cysteamine—SST—Signaling Pathways—YAP1—head and neck cancer	0.00152	0.00581	CbGpPWpGaD
Cysteamine—Feeling abnormal—Fluorouracil—head and neck cancer	0.00152	0.00488	CcSEcCtD
Cysteamine—Anaemia—Docetaxel—head and neck cancer	0.00151	0.00484	CcSEcCtD
Cysteamine—Urticaria—Fluorouracil—head and neck cancer	0.00146	0.00471	CcSEcCtD
Cysteamine—Leukopenia—Docetaxel—head and neck cancer	0.00146	0.00469	CcSEcCtD
Cysteamine—Body temperature increased—Fluorouracil—head and neck cancer	0.00146	0.00468	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—YAP1—head and neck cancer	0.00146	0.00557	CbGpPWpGaD
Cysteamine—MPO—C-MYB transcription factor network—HRAS—head and neck cancer	0.00143	0.00547	CbGpPWpGaD
Cysteamine—Convulsion—Docetaxel—head and neck cancer	0.00141	0.00454	CcSEcCtD
Cysteamine—Hypertension—Docetaxel—head and neck cancer	0.00141	0.00452	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.00138	0.00443	CcSEcCtD
Cysteamine—Hypersensitivity—Fluorouracil—head and neck cancer	0.00136	0.00436	CcSEcCtD
Cysteamine—Confusional state—Docetaxel—head and neck cancer	0.00134	0.00431	CcSEcCtD
Cysteamine—Anaphylactic shock—Docetaxel—head and neck cancer	0.00133	0.00428	CcSEcCtD
Cysteamine—Nervous system disorder—Docetaxel—head and neck cancer	0.0013	0.00419	CcSEcCtD
Cysteamine—Skin disorder—Docetaxel—head and neck cancer	0.00129	0.00415	CcSEcCtD
Cysteamine—Anorexia—Docetaxel—head and neck cancer	0.00127	0.00408	CcSEcCtD
Cysteamine—Diarrhoea—Fluorouracil—head and neck cancer	0.00126	0.00405	CcSEcCtD
Cysteamine—Dizziness—Fluorouracil—head and neck cancer	0.00122	0.00392	CcSEcCtD
Cysteamine—Somnolence—Docetaxel—head and neck cancer	0.00118	0.0038	CcSEcCtD
Cysteamine—Vomiting—Fluorouracil—head and neck cancer	0.00117	0.00377	CcSEcCtD
Cysteamine—Dyspepsia—Docetaxel—head and neck cancer	0.00117	0.00376	CcSEcCtD
Cysteamine—Rash—Fluorouracil—head and neck cancer	0.00116	0.00373	CcSEcCtD
Cysteamine—Dermatitis—Fluorouracil—head and neck cancer	0.00116	0.00373	CcSEcCtD
Cysteamine—Decreased appetite—Docetaxel—head and neck cancer	0.00116	0.00372	CcSEcCtD
Cysteamine—Headache—Fluorouracil—head and neck cancer	0.00115	0.00371	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.00115	0.00369	CcSEcCtD
Cysteamine—Fatigue—Docetaxel—head and neck cancer	0.00115	0.00369	CcSEcCtD
Cysteamine—Constipation—Docetaxel—head and neck cancer	0.00114	0.00366	CcSEcCtD
Cysteamine—Feeling abnormal—Docetaxel—head and neck cancer	0.0011	0.00352	CcSEcCtD
Cysteamine—Nausea—Fluorouracil—head and neck cancer	0.00109	0.00352	CcSEcCtD
Cysteamine—Gastrointestinal pain—Docetaxel—head and neck cancer	0.00109	0.0035	CcSEcCtD
Cysteamine—Abdominal pain—Docetaxel—head and neck cancer	0.00105	0.00338	CcSEcCtD
Cysteamine—Body temperature increased—Docetaxel—head and neck cancer	0.00105	0.00338	CcSEcCtD
Cysteamine—Hypersensitivity—Docetaxel—head and neck cancer	0.000979	0.00315	CcSEcCtD
Cysteamine—Asthenia—Docetaxel—head and neck cancer	0.000954	0.00307	CcSEcCtD
Cysteamine—Diarrhoea—Docetaxel—head and neck cancer	0.000909	0.00293	CcSEcCtD
Cysteamine—Dizziness—Docetaxel—head and neck cancer	0.000879	0.00283	CcSEcCtD
Cysteamine—SST—GPCR downstream signaling—IL2—head and neck cancer	0.000878	0.00336	CbGpPWpGaD
Cysteamine—Vomiting—Docetaxel—head and neck cancer	0.000845	0.00272	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—IL2—head and neck cancer	0.000842	0.00322	CbGpPWpGaD
Cysteamine—Rash—Docetaxel—head and neck cancer	0.000838	0.0027	CcSEcCtD
Cysteamine—Dermatitis—Docetaxel—head and neck cancer	0.000837	0.00269	CcSEcCtD
Cysteamine—Headache—Docetaxel—head and neck cancer	0.000833	0.00268	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—IL2—head and neck cancer	0.000797	0.00305	CbGpPWpGaD
Cysteamine—Nausea—Docetaxel—head and neck cancer	0.00079	0.00254	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—IL2—head and neck cancer	0.000764	0.00293	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—NOTCH1—head and neck cancer	0.000684	0.00262	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—NOTCH1—head and neck cancer	0.000656	0.00251	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—MAPK3—head and neck cancer	0.000641	0.00245	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—MAPK3—head and neck cancer	0.000614	0.00235	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—MAPK1—head and neck cancer	0.00061	0.00234	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—EGFR—head and neck cancer	0.00061	0.00233	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—MAPK1—head and neck cancer	0.000585	0.00224	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—EGFR—head and neck cancer	0.000585	0.00224	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—PIK3CA—head and neck cancer	0.000583	0.00223	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—PIK3CA—head and neck cancer	0.000559	0.00214	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—PIK3CA—head and neck cancer	0.000529	0.00203	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—PIK3CA—head and neck cancer	0.000507	0.00194	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—HRAS—head and neck cancer	0.00049	0.00187	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—AKT1—head and neck cancer	0.000476	0.00182	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—IL2—head and neck cancer	0.000471	0.0018	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—HRAS—head and neck cancer	0.000469	0.0018	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CCND1—head and neck cancer	0.000459	0.00176	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—AKT1—head and neck cancer	0.000456	0.00175	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—IL2—head and neck cancer	0.000452	0.00173	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PTEN—head and neck cancer	0.000443	0.0017	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CCND1—head and neck cancer	0.00044	0.00169	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—AKT1—head and neck cancer	0.000432	0.00166	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PTEN—head and neck cancer	0.000425	0.00163	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—AKT1—head and neck cancer	0.000414	0.00159	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—VEGFA—head and neck cancer	0.0004	0.00153	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—STAT3—head and neck cancer	0.000396	0.00152	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—VEGFA—head and neck cancer	0.000384	0.00147	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—STAT3—head and neck cancer	0.00038	0.00145	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—MAPK3—head and neck cancer	0.000379	0.00145	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—MAPK3—head and neck cancer	0.000363	0.00139	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—MAPK1—head and neck cancer	0.00036	0.00138	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—EGFR—head and neck cancer	0.00036	0.00138	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—MAPK1—head and neck cancer	0.000345	0.00132	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—EGFR—head and neck cancer	0.000345	0.00132	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PIK3CA—head and neck cancer	0.000313	0.0012	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—TP53—head and neck cancer	0.000302	0.00116	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PIK3CA—head and neck cancer	0.0003	0.00115	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—TP53—head and neck cancer	0.00029	0.00111	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—HRAS—head and neck cancer	0.000289	0.00111	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—HRAS—head and neck cancer	0.000277	0.00106	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—AKT1—head and neck cancer	0.000255	0.000978	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—AKT1—head and neck cancer	0.000245	0.000938	CbGpPWpGaD
